- Home
- MATH vs DRRX Comparison
MATH vs DRRX Comparison
Compare MATH & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MATH
- DRRX
- Stock Information
- Founded
- MATH 2015
- DRRX 1998
- Country
- MATH Hong Kong
- DRRX United States
- Employees
- MATH N/A
- DRRX N/A
- Industry
- MATH Finance/Investors Services
- DRRX Biotechnology: Pharmaceutical Preparations
- Sector
- MATH Finance
- DRRX Health Care
- Exchange
- MATH Nasdaq
- DRRX Nasdaq
- Market Cap
- MATH 44.7M
- DRRX 44.4M
- IPO Year
- MATH N/A
- DRRX 2000
- Fundamental
- Price
- MATH $1.00
- DRRX $1.01
- Analyst Decision
- MATH
- DRRX Buy
- Analyst Count
- MATH 0
- DRRX 2
- Target Price
- MATH N/A
- DRRX $5.00
- AVG Volume (30 Days)
- MATH 25.2K
- DRRX 68.2K
- Earning Date
- MATH 11-26-2024
- DRRX 11-13-2024
- Dividend Yield
- MATH N/A
- DRRX N/A
- EPS Growth
- MATH N/A
- DRRX N/A
- EPS
- MATH N/A
- DRRX N/A
- Revenue
- MATH $16,763,545.00
- DRRX $8,594,000.00
- Revenue This Year
- MATH N/A
- DRRX N/A
- Revenue Next Year
- MATH N/A
- DRRX $3.07
- P/E Ratio
- MATH N/A
- DRRX N/A
- Revenue Growth
- MATH 194.51
- DRRX N/A
- 52 Week Low
- MATH $0.80
- DRRX $0.48
- 52 Week High
- MATH $2.27
- DRRX $1.88
- Technical
- Relative Strength Index (RSI)
- MATH 32.80
- DRRX 26.89
- Support Level
- MATH $1.10
- DRRX $1.27
- Resistance Level
- MATH $1.25
- DRRX $1.36
- Average True Range (ATR)
- MATH 0.06
- DRRX 0.11
- MACD
- MATH -0.02
- DRRX -0.04
- Stochastic Oscillator
- MATH 10.25
- DRRX 2.62
About MATH Metalpha Technology Holding Limited
Metalpha Technology Holding Ltd is to enable the transition towards digital asset technology. The company aims to provide a crypto derivatives product services for users world-wide. The company has three operating segments. The Longyun operating segment reflects the Company's crowdfunding and incubation business. The Dacheng Liantong operating segment reflects the Company's business of platform services. The Metalpha operating segment reflects the Company's business of proprietary trading of digital assets. The Company is generates its revenue from Hong Kong.
About DRRX DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .